Isracann Biosciences Inc. (ISCNF) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - Specialty & Generic Branche. Der Hauptsitz des Unternehmens ist in Vancouver, BC, Canada. Der aktuelle CEO ist Ajay Singh Kaila.
ISCNF hat IPO-Datum 2017-12-15, gelistet an der Other OTC, eine Marktkapitalisierung von $1.98K.
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
